Skip to main content

Advertisement

SpringerLink
Log in

Epilepsy coexisting with depression

  • Review article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Depression episodes in epilepsy is the most common commorbidity, affecting between 11% and 62% of patients with epilepsy. Although researchers have documented a strong association between epilepsy and psychiatric comorbidities, the nature of this relationship is poorly understood.

The manifestation of depression in epilepsy is a complex issue having many interacting neurobiological and psychosocial determinants, including clinical features of epilepsy (seizure frequency, type, foci, or lateralization of foci) and neurochemical or iatrogenic mechanisms. Other risk factors are a family history of psychiatric illness, particularly depression, a lack of control over the seizures and iatrogenic causes (pharmacologic and surgical). In addition, treatment with antiepileptic drugs (AEDs) as well as social coping and adaptation skills have also been recognised as risk factors of depression associated with epilepsy.

Epilepsy may foster the development of depression through being exposed to chronic stress. The uncertainty and unpredictability of seizures may instigate sadness, loneliness, despair, low self-esteem, and self-reproach in patients with epilepsy and lead to social isolation, stigmatization, or disability. Often, depression is viewed as a reaction to epilepsy’s stigma and the associated poor quality of life. Moreover, patients with epilepsy display a 4–5 higher rate of depression and suicide compared with healthy population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moshe SL, Perucca E, Ryvlin P, Tomson T. Epilepsy: new advances. Lancet 2015;385:884–98.

    Article  PubMed  Google Scholar 

  2. Mazarati A, Pineda E, Shin D, Tio D, Taylor AN, Sankar R. Comorbidity between epilepsy and depression: role of hippocampal interleukin-1β. Neurobiol Dis 2010;37:461–7.

    Article  CAS  PubMed  Google Scholar 

  3. Kanner AM, Schachter S, Barry JJ, Hesdorffer DC, Mula M, Trimble M, et al Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy Behav 2012;24:156–68.

    Article  PubMed  Google Scholar 

  4. Temkin O. The Falling Sickness. Baltimore: John Hopkins University Press; 1950.

    Google Scholar 

  5. Trimble MR, Reynolds EH. Anticonvulsant drugs and mental symptoms: a review. Psychol Med 1976;6:169–78.

    Article  CAS  PubMed  Google Scholar 

  6. Trimble MR. Anticonvulsant drugs, behavior, and cognitive abilities. Curr Dev Psychopharmacol 1981;6:65–91.

    Article  CAS  PubMed  Google Scholar 

  7. Robertson MM, Trimble MR, Townsend HR. Phenomenology of depression in epilepsy. Epilepsia 1987;28(4):364–72.

    Article  CAS  PubMed  Google Scholar 

  8. Robertson MM, Trimble MR. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 1985;9:127–36.

    Article  CAS  PubMed  Google Scholar 

  9. Andreasen NC, Endicott J, Spitzer RL, Winokur G. The family history metod using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977;34:1229–35.

    Article  CAS  PubMed  Google Scholar 

  10. Kovacs M. Presentation and course of major depressive disorder Turing childhood and later years of the life span. J Am Acad Child Adolesc Psychiatry 1996;35:705–15.

    Article  CAS  PubMed  Google Scholar 

  11. Jackson MJ, Turkington D. Depression and anxiety in epilepsy. J. Neurol. Neurosurg Psychiatry 2005;76(Suppl. 1):i45–7.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Piedad J, Rickards H, Besag FM, Cavanna AE. Beneficial and adverse effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations. CNS Drugs 2012;26: 319–35.

    Article  CAS  PubMed  Google Scholar 

  13. Bowman ES, Markand ON. Psychodynamics and psychiatric diagnoses of pseudoseizure subjects. Am J Psychiatry 1996;153:57–63.

    Article  CAS  PubMed  Google Scholar 

  14. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007;48:2336–44.

    PubMed  Google Scholar 

  15. Wiegartz P, Seidenberg M, Woodard A, Gidal B, Hermann B. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999;53(Suppl. 2):S3–8.

    CAS  PubMed  Google Scholar 

  16. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry 2000;8:8–17.

    Article  CAS  PubMed  Google Scholar 

  17. Mula M. The interictal dysphoric disorder. In: Trimble MR, Schmitz B, editors. The Neuropsychiatry of Epilepsy. 2nd edition Cambridge: Cambridge University Press; 2011. p. 80–7.

    Chapter  Google Scholar 

  18. Mendez MF, Cummings JL, Benson DF. Depression in epilepsy: significance and phenomenology. Arch Neurol 1986;43:766–70.

    Article  CAS  PubMed  Google Scholar 

  19. Kanner AM. Depression and epilepsy: a new perspective on two closely related disorders. Epilepsy Curr 2006;6:141–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Schmitz EB, Moriarty J, Costa DC, Ring HA, Ell PJ, Trimble MR. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy. J Neurol Neurosurg Psychiatry 1997;62: 458–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. van Elst LT, Woermann FG, Lemieux L, Trimble MR. Amygdala enlargement in dysthymia—a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry 1999;46:1614–23.

    Article  Google Scholar 

  22. Schmitz B. The effects of antiepileptic drugs on behavior. In: Trimble MR, Schmitz B, editors. The Neuropsychiatry of Epilepsy. Cambridge: Cambridge University Press; 2002. p. 241–55.

    Chapter  Google Scholar 

  23. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000;47:246–9.

    Article  CAS  PubMed  Google Scholar 

  24. Hesdorffer DC, Ludvigsson P, Hauser WA, Olafsson E, Kjartansson O. Co-occurrence of major depression or suicide attempt with migraine with aura and risk forunprovoked seizure. Epilepsy Res 2007;75:220–3.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Forsgren L, Nystrom L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res 1990;6:66–81.

    Article  CAS  PubMed  Google Scholar 

  26. Hesdorffer DC, Hauser WA, Olafsson E, Ludvigsson P, Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2005;59:35–41.

    Article  Google Scholar 

  27. Hitiris N, Mohanraj R, Norrie J, Sills GJ, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007;75:192–6.

    Article  CAS  PubMed  Google Scholar 

  28. Kanner AM, Byrne R, Chicharro A, Wuu J, Frey M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology 2009;72:793–9.

    Article  CAS  PubMed  Google Scholar 

  29. Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007;48:2336–44.

    PubMed  Google Scholar 

  30. Kondziella D, Alvestad S, Vaaler A, Sonnewald U. Which clinical and experimental data link temporal lobe epilepsy with depression? J Neurochem 2007;103:2136–52.

    Article  CAS  PubMed  Google Scholar 

  31. Machado-Vieira R, Salvadore G, Ibrahim LA, Diaz-Granados N, Zarate Jr. CA. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders. Curr Pharm Des 2009;15:1595–611.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005;10:808–19.

    Article  PubMed  Google Scholar 

  33. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721–37.

    Article  CAS  PubMed  Google Scholar 

  34. Zobel A, Wellmer J, Schulze-Rauschenbach S, Pfeiffer U, Schnell S, Elger C, Maier W. Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy. Eur Arch Psychiatry Clin Neurosci 2004;254:303–11.

    Article  PubMed  Google Scholar 

  35. Bilevicius E, Yasuda CL, Silva MS, Guerreiro CA, Lopes-Cendes I, Cendes F. Antiepileptic drug response in temporal lobe epilepsy: a clinical and MRI morphometry study. Neurology 2010;75:1695–701.

    Article  CAS  PubMed  Google Scholar 

  36. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003;160:1516–8.

    Article  PubMed  Google Scholar 

  37. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry 2000;157:115–8.

    Article  CAS  PubMed  Google Scholar 

  38. Kanner A. Is depression associated with an increased risk of treatment-resistant epilepsy: Research strategies to investigate this question. Epilepsy Behav 2014;38:3–7.

    Article  PubMed  Google Scholar 

  39. Levinson AJ, Fitzgerald PB, Favallli G, Blumberger DM, Daigle M, Daskalakis ZJ. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry 2010;67:458–64.

    Article  CAS  PubMed  Google Scholar 

  40. Craddock N, Forty L. Genetics of affective (mood) disorders. Eur J Hum Genet 2006;14:660–8.

    Article  CAS  PubMed  Google Scholar 

  41. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, Faas BH, et al. CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 2008;13:261–6.

    Article  CAS  PubMed  Google Scholar 

  42. Heiman GA, Kamberakis K, Gill R, Kalachikov S, Pedley TA, Hauser WA, et al. Evaluation of depression risk in LGI1 mutation carriers. Epilepsia 2010;51:1685–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Lacey CJ, Salzberg MR, D’souza WJ. Serotonin transporter gene × environment and risk of depression in community-treated epilepsy Epilepsy. Behav 2014;39: 33–7.

    Google Scholar 

  44. Devinsky O, Luciano D. Psychic phenomena in partial seizures. Semin Neurol 1991;11:100–9.

    Article  CAS  PubMed  Google Scholar 

  45. Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J Nerv Ment Dis 1986;174:471–6.

    Article  CAS  PubMed  Google Scholar 

  46. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 1999;40(Suppl. 10):S21–47.

    Article  CAS  PubMed  Google Scholar 

  47. Kanner AM, Palac S. Depression in epilepsy: a common but often unrecognized comorbid malady. Epilepsy Behav 2000;1:37–51.

    Article  CAS  PubMed  Google Scholar 

  48. Gilliam FG, Barry JJ, Hermann BP, Meador KJ, Vahle V, Kanner AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006;5:399–405.

    Article  PubMed  Google Scholar 

  49. Rampling J, Mitchell AJ, Von Oertzen T, Docker J, Jackson J, Cock H, et al. Screening for depression in epilepsy clinics: a comparison of conventional and visual-analog methods. Epilepsia 2012;53:1713–21.

    Article  PubMed  Google Scholar 

  50. Drinovac M, Wagner H, Agrawal N, Cock HR, Mitchell AJ, von Oertzen TJ. Screening for depression in epilepsy: a model of an enhanced screening tool. Epilepsy Behav 2015;44:67–72.

    Article  PubMed  Google Scholar 

  51. de Oliveira GN, Lessa JM, Gonçalves AP, Portela EJ, Sander JW, Teixeira AL Screening for depression in people with epilepsy: comparative study among Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Hospital Anxiety and Depression Scale Depression Subscale (HADS-D), and Beck Depression Inventory (BDI). Epilepsy Behav 2014;34:50–4.

    Article  PubMed  Google Scholar 

  52. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interviewfor DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl. 20):22–33.

    PubMed  Google Scholar 

  53. Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003;54:388–98.

    Article  PubMed  Google Scholar 

  54. Price JL. Prefrontal cortical networks related to visceral function and mood. Ann N Y Acad Sci 1999;877:383–96.

    Article  CAS  PubMed  Google Scholar 

  55. Giovacchini G, Toczek MT, Bonwetsch R, Bagic A, Lang L, Fraser C, et al. 5–HT1A receptors are reduced in temporal lobe epilepsy after partial-volume correction. J Nucl Med 2005;46:1128–35.

    PubMed  Google Scholar 

  56. Theodore WH, Hasler G, Giovacchini G, Kelley K, Reeves-Tyer P, Herscovitch P, et al. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 2007;48:1526–30.

    Article  PubMed  Google Scholar 

  57. Gilliam FG, Santos J, Vahle V, Carter J, Brown K, Hecimovic H. Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction? Epilepsia 2004;45:28–33.

    Article  PubMed  Google Scholar 

  58. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22:607–15.

    Article  CAS  PubMed  Google Scholar 

  59. Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Mayberg HS. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimaging Clin N Am 2003;13:805–15.

    Article  PubMed  Google Scholar 

  61. Buchsbaum MS, Wu J, Siegel BV, Hackett E, Trenary M, Abel L, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 1997;41:15–22.

    Article  CAS  PubMed  Google Scholar 

  62. Davidson RJ, Jackson DC, Kalin NH. Emotion, plasticity, context, and regulation: perspectives from affective neuroscience. Psychol. Bull. 2000;126:890–909.

    Article  PubMed  Google Scholar 

  63. Gloag D. Epilepsy and employment. Br Med J 1985;291:2–3.

    Article  CAS  Google Scholar 

  64. Economou M, Madianos M, Peppou LE, Theleritis C, Patelakis A, Stefanis C. Suicidal ideation and reported suicide attempts in Greece during the economic crisis. World Psychiatry 2013;12(1):53–9.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Dias R, Bateman LM, Farias ST, Li CS, Lin TC, Jorgensen J, et al. Depression in epilepsy is associated with lack of seizure control. Epilepsy Behav 2010;19:445–7.

    Article  PubMed  Google Scholar 

  66. Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: finding from a U.K. ticommunity study. Epilepsia 1996;37:148–61.

    Article  CAS  PubMed  Google Scholar 

  67. O’Donoghue MF, Goodridge DM, Redhead K, Sander JW, Duncan JS. Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract 1999;49:211–4.

    PubMed  PubMed Central  Google Scholar 

  68. Thapar A, Roland M, Harold G. Do depression symptoms predict seizure frequency—or vice versa? J Psychosom Res 2005;59:269–74.

    Article  PubMed  Google Scholar 

  69. Cavanna AE, Cavanna S, Bertero L, Robertson MM. Depression in women with epilepsy: clinical and neurobiological aspects. Funct Neurol 2009;24:83–7.

    PubMed  Google Scholar 

  70. Madianos MG, Zartaloudi A, Alevizopoulos G, Katostaras T. Attitudes toward helpseeking and duration of untreated mental disorders in a sectorized Athens area of Greece. Commun Ment Health J 2011;47:583–93.

    Article  Google Scholar 

  71. Lacey CJ, Salzberg MR, D’souza W. Risk factors for depression in community-treated epilepsy: systematic review. Epilepsy Behav 2015;43:1–7.

    Article  PubMed  Google Scholar 

  72. Naess S, Eriksen J, Tambs K. Psychological well-being of people with epilepsy in Norway. Epilepsy Behav 2007;11:310–5.

    Article  PubMed  Google Scholar 

  73. Thapar A, Kerr M, Harold G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav 2009;14:134–40.

    Article  PubMed  Google Scholar 

  74. Mensah SA, Beavis JM, Thapar AK, Kerr M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy Behav 2006;8:213–9.

    Article  PubMed  Google Scholar 

  75. Stefanello S, Marin-Leon L, Fernandes PT, Li LM, Botega NJ. Psychiatric comorbidityand suicidal behavior in epilepsy: a community-based case-control study. Epilepsia 2010;51:1120–5.

    Article  PubMed  Google Scholar 

  76. Kanner AM. The treatment of depressive disorders in epilepsy: What all neurologists should know. Epilepsia 2013;54(Suppl. 1):1–12.

    PubMed  Google Scholar 

  77. Seminario NA, Farias ST, Jorgensen J, Bourgeois JA, Seyal M. Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire. Epilepsy Behav 2009;15:362–6.

    Article  PubMed  Google Scholar 

  78. Ciechanowski P, Chaytor N, Miller J, Fraser R, Russo J, Unutzer J, Gilliam F. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav 2010;19:225–31.

    Article  PubMed  Google Scholar 

  79. Hoppe C, Elger CE. Depression in epilepsy: a critical review from a clinical perspective. Nat Rev Neurol 2011;7:462–72.

    Article  PubMed  Google Scholar 

  80. Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004;27:133–6.

    Article  CAS  PubMed  Google Scholar 

  81. Garcia-Morales I, de la Pena Mayor P, Kanner AM. Psychiatric comorbidities in epilepsy: identification and treatment. Neurologist 2008;14:S15–25.

    Article  PubMed  Google Scholar 

  82. Charney DS, Berman RM, Miller HL. Treatment of depression. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology. 2nd ed. Washington DC: American Psychiatric Association Press; 1998. p. 705–32.

    Google Scholar 

  83. Zarate Jr. CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63:856–64.

    Article  CAS  PubMed  Google Scholar 

  84. Paykel ES, Ramana R, Cooper Z. Residual symptoms after partial remission; an important outcome in depression. Psychol Med 1995;25:1171–80.

    Article  CAS  PubMed  Google Scholar 

  85. Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008;13:S1–S29.

    Article  PubMed  Google Scholar 

  86. Preskorn S, Fast G. Tricyclic antidepressant induced seizures and plasma drug concentration. J Clin Psychol 1992;53:160–2.

    CAS  Google Scholar 

  87. Jones JE, Hermann BP, Barry JJ, Gilliam FG, Kanner AM, Meador KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003;4(Suppl. 3):S31–8.

    Article  PubMed  Google Scholar 

  88. Brent DA, Crumrine PK, Varma RR, Allan M, Allman C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 1987;80:909–17.

    CAS  PubMed  Google Scholar 

  89. Mula M, Trimble MR, Yuen A, Liu RS, Sander JW. Psychiatric adverse events during levetiracetam therapy. Neurology 2003;61:704–6.

    Article  CAS  PubMed  Google Scholar 

  90. Mula M, Sander JW. Suicidal ideation in epilepsy and levetiracetam therapy. Epilepsy Behav 2007;11:130–2.

    Article  PubMed  Google Scholar 

  91. Mula M, Hesdorffer DC, Trimble M, Sander JW. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia 2009;50:1072–6.

    Article  PubMed  Google Scholar 

  92. Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia 2011;52:2181–91.

    Article  PubMed  Google Scholar 

  93. Cramer JA, Blum D, Fanning K, Reed M. The impact ofcomorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav 2004;5:337–42.

    Article  PubMed  Google Scholar 

  94. Attarian H, Vahle V, Carter J, Hykes E, Gilliam F. Relationship between depression and intractability of seizures. Epilepsy Behav 2003;4:298–301.

    Article  CAS  PubMed  Google Scholar 

  95. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007;6:693–8.

    Article  PubMed  Google Scholar 

  96. Kanner AM. Epilepsy, suicidal behaviour, and depression: do they share common pathogenic mechanisms? Lancet Neurol 2006;5:107–8.

    Article  PubMed  Google Scholar 

  97. Fazel S, Wolf A, Långström N, Newton CR, Lichtenstein P. Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study. Lancet 2013;382:1646–54.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Andersen SL, Teicher MH. Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuse. Neurosci Biobehav Rev 2009;33:516–24.

    Article  PubMed  Google Scholar 

  99. Hamilton KT, Anderson CT, Dahodwala N, Lawler K, Hesdorffer D, French J, Pollard JR. Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression. Seizure 2014;23:196–200.

    Article  PubMed  Google Scholar 

  100. Asadi-Pooya AA, Sperling MR. Antiepileptic Drugs: A Clinician’s Manual. Oxford: Univeristy Press; 2009.

    Google Scholar 

  101. Kanner AM. Depression in Neurological Disorders. Cambridge: Lundbeck Institute; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Health Sciences, High School of Economics, Law and Medical Sciences, Kielce, Poland

    Barbara Błaszczyk

  2. Private Neurological Practice, Kielce, Poland

    Barbara Błaszczyk

  3. Department of Pathophysiology, Medical University of Lublin, Lublin, Poland

    Stanisław J. Czuczwar

  4. Department of Physiopathology, Institute of Rural Health, Lublin, Poland

    Stanisław J. Czuczwar

Authors
  1. Barbara Błaszczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanisław J. Czuczwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Barbara Błaszczyk or Stanisław J. Czuczwar.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Błaszczyk, B., Czuczwar, S.J. Epilepsy coexisting with depression. Pharmacol. Rep 68, 1084–1092 (2016). https://doi.org/10.1016/j.pharep.2016.06.011

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2016.06.011

Keywords

Search

Navigation